Introduction:
Prediabetes is a growing global health burden associated with elevated cardiovascular risk well before overt diabetes. Although glucagon-like peptide-1 receptor agonists (GLP-1RAs) confer cardiovascular benefit in type 2 diabetes and obesity, real-world data in overweight or obese adults with prediabet...
F. Qtaishat, H. Alhammouri, J. Yasin et al.· Circulation· 0 citations
Introduction:
Obstructive sleep apnea (OSA) and obesity are established risk factors for atrial fibrillation (AF) through shared mechanisms including chronic intermittent hypoxia, sympathetic activation, and atrial remodeling. GLP-1 receptor agonists (GLP-1 RA) and SGLT2 inhibitors (SGLT2i) are increasingly used in...
Zaid Al-Kofahi, H. Alhammouri, F. Qtaishat et al.· Circulation· 0 citations
AIM
To explore the barriers and facilitators to maintaining cardiovascular health among Syrian refugees living in the Zaatari camp.
DESIGN
A qualitative study guided by the Social Determinants of Health framework.
METHODS
Focus group discussions were conducted with 13 Syrian refugees. Twelve themes were identified,...
Abeer Alharthi, Hind Alzahrani, Rawnaq Behnam et al.· Journal of Advanced Nursing· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.